AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (Q2043834): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in 2 languages: Changing unique label-description pair) |
(Removed claim: financed by (P890): Directorate-General for Regional and Urban Policy (Q8361), Removing unnecessary financed by statement) |
||
Property / financed by | |||
Property / financed by: Directorate-General for Regional and Urban Policy / rank | |||
Revision as of 08:41, 2 November 2020
Project Q2043834 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING |
Project Q2043834 in Italy |
Statements
15,000.0 Euro
0 references
30,000.0 Euro
0 references
50.0 percent
0 references
25 October 2017
0 references
15 October 2018
0 references
30 December 2019
0 references
ARDIS S.R.L.
0 references
AN INNOVATIVE TECHNOLOGY PLATFORM FOR THE DEVELOPMENT AND COMMERCIALISATION OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY PRE-TREATMENT DIAGNOSTIC TESTING (Italian)
0 references
AN INNOVATIVE TECHNICAL PLATFORM FOR THE DEVELOPMENT AND TRADE OF ANTIBODY-BASED CANCER THERAPEUTICS SUPPORTED BY DIAGNOSTIC TESTING (English)
0 references
Identifiers
E17F17000030002
0 references